We want to highlight the fruitful collaborations in the cluster. In a new article series, we present members who have a cluster story to tell. This week, we meet LINK Medical.
Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.
Five new partners have joined CONNECT.
Eva S. Dugstad is our new research and industry facilitator aka competence broker for Oslo-based companies.
We regularly publish new videos to our YouTube channel. Please subscribe to stay up-to-date via the link below.